AA
51
3
HAS
30
2
GM
65
-3
RSG
68
3
AZO
46
-3
IFF
53
2
SRE
63
-3
LB
34
8
INTU
51
2
EFX
32
2
TXT
48
2
MS
74
-2
ACN
47
-2
EIX
77
2
FRT
39
-2
MTB
63
-2
VRTX
46
2
BMY
53
-7
HSY
34
3
DVA
72
2
AA
51
3
HAS
30
2
GM
65
-3
RSG
68
3
AZO
46
-3
IFF
53
2
SRE
63
-3
LB
34
8
INTU
51
2
EFX
32
2
TXT
48
2
MS
74
-2
ACN
47
-2
EIX
77
2
FRT
39
-2
MTB
63
-2
VRTX
46
2
BMY
53
-7
HSY
34
3
DVA
72
2
Financhill
Back

ACADIA Pharmaceuticals Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39

ACAD
ACADIA Pharmaceuticals

Last Price:
16.20
Seasonality Move:
23.29%

7 Day Trial

ALL ACCESS PASS

$ 7

Access The Stock Grader Trading Tool From "The King Of Quants"

More details here...

ACADIA Pharmaceuticals Price Quote

$16.20
-0.07 (-0.43%)
(Updated: November 21, 2024 at 5:55 PM ET)

ACADIA Pharmaceuticals Key Stats

Sell
39
ACADIA Pharmaceuticals (ACAD) is a Sell
Day range:
$16.05 - $16.39
52-week range:
$14.15 - $32.59
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.91
P/B ratio:
4.69%
Volume:
1.1M
Avg. volume:
1.3M
1-year change:
-29.01%
Market cap:
$2.7B
Revenue:
$726.4M
EPS:
$0.78

How Much Does ACADIA Pharmaceuticals Make?

Is ACADIA Pharmaceuticals Growing As A Company?

ACADIA Pharmaceuticals Stock Price Performance

What Is ACADIA Pharmaceuticals 52-Week High & Low?

ACADIA Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy ACADIA Pharmaceuticals?

Is ACADIA Pharmaceuticals Cash Flow Positive?

  • What Is ACAD Cash Flow From Operations?
    Cash flow from operations (TTM) is $202.7M
  • What Is ACADIA Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $10.3M
  • What Is ACADIA Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$153M

ACADIA Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    ACAD return on invested capital is 27.32%
  • What Is ACADIA Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 15.57%
  • What Is ACAD Return On Equity?
    ROE is a measure of profitability and is 27.32%

ACADIA Pharmaceuticals Earnings Date & Stock Price

ACADIA Pharmaceuticals Competitors

ACADIA Pharmaceuticals Dividend Yield

ACADIA Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 41.23%
Revenue: 18.28% 0.63%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 25.11
Upside from Last Price: 54.3%

Major Shareholders

  • How many ACAD shares are owned by institutional investors?
    227.8M ACAD shares are owned by institutional investors
  • How many ACAD shares are owned by insiders?
    1.1M ACAD shares are owned by insiders